nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—RXRG—coronary artery disease	0.465	1	CbGaD
Bexarotene—CYP2C9—Fenofibrate—coronary artery disease	0.0258	0.0912	CbGbCtD
Bexarotene—CYP2C9—Gemfibrozil—coronary artery disease	0.0206	0.0729	CbGbCtD
Bexarotene—CYP2C9—Clopidogrel—coronary artery disease	0.0179	0.0632	CbGbCtD
Bexarotene—CYP3A4—Ticagrelor—coronary artery disease	0.0168	0.0595	CbGbCtD
Bexarotene—CYP2C9—Pitavastatin—coronary artery disease	0.0156	0.0553	CbGbCtD
Bexarotene—CYP2C9—Valsartan—coronary artery disease	0.0152	0.0538	CbGbCtD
Bexarotene—CYP3A4—Fenofibrate—coronary artery disease	0.015	0.053	CbGbCtD
Bexarotene—CYP3A4—Gemfibrozil—coronary artery disease	0.012	0.0424	CbGbCtD
Bexarotene—CYP2C9—Rosuvastatin—coronary artery disease	0.0115	0.0407	CbGbCtD
Bexarotene—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.0112	0.0397	CbGbCtD
Bexarotene—CYP2C9—Simvastatin—coronary artery disease	0.0107	0.0379	CbGbCtD
Bexarotene—CYP2C9—Pravastatin—coronary artery disease	0.0105	0.0371	CbGbCtD
Bexarotene—CYP2C9—Lovastatin—coronary artery disease	0.0105	0.0371	CbGbCtD
Bexarotene—CYP3A4—Clopidogrel—coronary artery disease	0.0104	0.0368	CbGbCtD
Bexarotene—CYP3A4—Eplerenone—coronary artery disease	0.00965	0.0342	CbGbCtD
Bexarotene—CYP2C9—Atorvastatin—coronary artery disease	0.00953	0.0338	CbGbCtD
Bexarotene—CYP2C9—Losartan—coronary artery disease	0.00872	0.0309	CbGbCtD
Bexarotene—CYP3A4—Enalapril—coronary artery disease	0.0086	0.0305	CbGbCtD
Bexarotene—CYP3A4—Rosuvastatin—coronary artery disease	0.00669	0.0237	CbGbCtD
Bexarotene—CYP3A4—Ezetimibe—coronary artery disease	0.00669	0.0237	CbGbCtD
Bexarotene—CYP3A4—Simvastatin—coronary artery disease	0.00622	0.022	CbGbCtD
Bexarotene—CYP3A4—Lovastatin—coronary artery disease	0.00609	0.0216	CbGbCtD
Bexarotene—CYP3A4—Pravastatin—coronary artery disease	0.00609	0.0216	CbGbCtD
Bexarotene—CYP3A4—Atorvastatin—coronary artery disease	0.00554	0.0196	CbGbCtD
Bexarotene—CYP3A4—Losartan—coronary artery disease	0.00507	0.018	CbGbCtD
Bexarotene—CYP2C9—cardial valve—coronary artery disease	0.00425	0.457	CbGeAlD
Bexarotene—RXRB—myocardium—coronary artery disease	0.00115	0.123	CbGeAlD
Bexarotene—RXRG—heart—coronary artery disease	0.000851	0.0915	CbGeAlD
Bexarotene—RXRG—cardiovascular system—coronary artery disease	0.000803	0.0863	CbGeAlD
Bexarotene—RXRB—heart—coronary artery disease	0.0008	0.086	CbGeAlD
Bexarotene—RXRB—cardiac atrium—coronary artery disease	0.000685	0.0736	CbGeAlD
Bexarotene—CYP2C9—heart—coronary artery disease	0.000235	0.0253	CbGeAlD
Bexarotene—CYP2C9—cardiovascular system—coronary artery disease	0.000222	0.0238	CbGeAlD
Bexarotene—CYP2C9—blood—coronary artery disease	0.000175	0.0189	CbGeAlD
Bexarotene—CYP3A4—blood—coronary artery disease	0.000134	0.0144	CbGeAlD
Bexarotene—Decreased appetite—Losartan—coronary artery disease	3.31e-05	0.00021	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	3.31e-05	0.000209	CcSEcCtD
Bexarotene—Abdominal pain—Captopril—coronary artery disease	3.31e-05	0.000209	CcSEcCtD
Bexarotene—Body temperature increased—Captopril—coronary artery disease	3.31e-05	0.000209	CcSEcCtD
Bexarotene—Dizziness—Simvastatin—coronary artery disease	3.3e-05	0.000209	CcSEcCtD
Bexarotene—Rash—Ezetimibe—coronary artery disease	3.3e-05	0.000209	CcSEcCtD
Bexarotene—Dermatitis—Ezetimibe—coronary artery disease	3.3e-05	0.000208	CcSEcCtD
Bexarotene—Confusional state—Ramipril—coronary artery disease	3.3e-05	0.000208	CcSEcCtD
Bexarotene—Discomfort—Timolol—coronary artery disease	3.29e-05	0.000208	CcSEcCtD
Bexarotene—Asthenia—Niacin—coronary artery disease	3.29e-05	0.000208	CcSEcCtD
Bexarotene—Fatigue—Losartan—coronary artery disease	3.29e-05	0.000208	CcSEcCtD
Bexarotene—Headache—Ezetimibe—coronary artery disease	3.28e-05	0.000207	CcSEcCtD
Bexarotene—Malaise—Lisinopril—coronary artery disease	3.28e-05	0.000207	CcSEcCtD
Bexarotene—Oedema—Ramipril—coronary artery disease	3.27e-05	0.000207	CcSEcCtD
Bexarotene—Vertigo—Lisinopril—coronary artery disease	3.26e-05	0.000206	CcSEcCtD
Bexarotene—Dry mouth—Timolol—coronary artery disease	3.26e-05	0.000206	CcSEcCtD
Bexarotene—Pain—Losartan—coronary artery disease	3.26e-05	0.000206	CcSEcCtD
Bexarotene—Constipation—Losartan—coronary artery disease	3.26e-05	0.000206	CcSEcCtD
Bexarotene—Syncope—Lisinopril—coronary artery disease	3.26e-05	0.000206	CcSEcCtD
Bexarotene—Vomiting—Eplerenone—coronary artery disease	3.26e-05	0.000206	CcSEcCtD
Bexarotene—Feeling abnormal—Furosemide—coronary artery disease	3.26e-05	0.000206	CcSEcCtD
Bexarotene—Leukopenia—Lisinopril—coronary artery disease	3.25e-05	0.000206	CcSEcCtD
Bexarotene—Nausea—Fenofibrate—coronary artery disease	3.25e-05	0.000205	CcSEcCtD
Bexarotene—Pruritus—Niacin—coronary artery disease	3.24e-05	0.000205	CcSEcCtD
Bexarotene—Asthenia—Pravastatin—coronary artery disease	3.24e-05	0.000205	CcSEcCtD
Bexarotene—Gastrointestinal pain—Furosemide—coronary artery disease	3.23e-05	0.000204	CcSEcCtD
Bexarotene—Rash—Eplerenone—coronary artery disease	3.23e-05	0.000204	CcSEcCtD
Bexarotene—Hypersensitivity—Trandolapril—coronary artery disease	3.23e-05	0.000204	CcSEcCtD
Bexarotene—Dermatitis—Eplerenone—coronary artery disease	3.23e-05	0.000204	CcSEcCtD
Bexarotene—Diarrhoea—Valsartan—coronary artery disease	3.23e-05	0.000204	CcSEcCtD
Bexarotene—Confusional state—Timolol—coronary artery disease	3.22e-05	0.000204	CcSEcCtD
Bexarotene—Shock—Ramipril—coronary artery disease	3.22e-05	0.000203	CcSEcCtD
Bexarotene—Hypersensitivity—Enalapril—coronary artery disease	3.22e-05	0.000203	CcSEcCtD
Bexarotene—Body temperature increased—Perindopril—coronary artery disease	3.21e-05	0.000203	CcSEcCtD
Bexarotene—Abdominal pain—Perindopril—coronary artery disease	3.21e-05	0.000203	CcSEcCtD
Bexarotene—Palpitations—Lisinopril—coronary artery disease	3.21e-05	0.000203	CcSEcCtD
Bexarotene—Diarrhoea—Olmesartan—coronary artery disease	3.21e-05	0.000203	CcSEcCtD
Bexarotene—Headache—Eplerenone—coronary artery disease	3.21e-05	0.000203	CcSEcCtD
Bexarotene—Nervous system disorder—Ramipril—coronary artery disease	3.21e-05	0.000203	CcSEcCtD
Bexarotene—Thrombocytopenia—Ramipril—coronary artery disease	3.2e-05	0.000202	CcSEcCtD
Bexarotene—Oedema—Timolol—coronary artery disease	3.2e-05	0.000202	CcSEcCtD
Bexarotene—Pruritus—Pravastatin—coronary artery disease	3.19e-05	0.000202	CcSEcCtD
Bexarotene—Loss of consciousness—Lisinopril—coronary artery disease	3.19e-05	0.000202	CcSEcCtD
Bexarotene—Nausea—Clopidogrel—coronary artery disease	3.19e-05	0.000202	CcSEcCtD
Bexarotene—Tachycardia—Ramipril—coronary artery disease	3.19e-05	0.000202	CcSEcCtD
Bexarotene—Skin disorder—Ramipril—coronary artery disease	3.18e-05	0.000201	CcSEcCtD
Bexarotene—Infection—Timolol—coronary artery disease	3.18e-05	0.000201	CcSEcCtD
Bexarotene—Vomiting—Simvastatin—coronary artery disease	3.17e-05	0.000201	CcSEcCtD
Bexarotene—Hypersensitivity—Telmisartan—coronary artery disease	3.17e-05	0.000201	CcSEcCtD
Bexarotene—Cough—Lisinopril—coronary artery disease	3.17e-05	0.0002	CcSEcCtD
Bexarotene—Nausea—Lovastatin—coronary artery disease	3.17e-05	0.0002	CcSEcCtD
Bexarotene—Hyperhidrosis—Ramipril—coronary artery disease	3.16e-05	0.0002	CcSEcCtD
Bexarotene—Rash—Simvastatin—coronary artery disease	3.15e-05	0.000199	CcSEcCtD
Bexarotene—Dermatitis—Simvastatin—coronary artery disease	3.15e-05	0.000199	CcSEcCtD
Bexarotene—Asthenia—Trandolapril—coronary artery disease	3.14e-05	0.000199	CcSEcCtD
Bexarotene—Shock—Timolol—coronary artery disease	3.14e-05	0.000199	CcSEcCtD
Bexarotene—Feeling abnormal—Losartan—coronary artery disease	3.14e-05	0.000199	CcSEcCtD
Bexarotene—Diarrhoea—Niacin—coronary artery disease	3.14e-05	0.000198	CcSEcCtD
Bexarotene—Nervous system disorder—Timolol—coronary artery disease	3.13e-05	0.000198	CcSEcCtD
Bexarotene—Asthenia—Enalapril—coronary artery disease	3.13e-05	0.000198	CcSEcCtD
Bexarotene—Headache—Simvastatin—coronary artery disease	3.13e-05	0.000198	CcSEcCtD
Bexarotene—Abdominal pain—Furosemide—coronary artery disease	3.12e-05	0.000197	CcSEcCtD
Bexarotene—Body temperature increased—Furosemide—coronary artery disease	3.12e-05	0.000197	CcSEcCtD
Bexarotene—Gastrointestinal pain—Losartan—coronary artery disease	3.12e-05	0.000197	CcSEcCtD
Bexarotene—Dizziness—Valsartan—coronary artery disease	3.12e-05	0.000197	CcSEcCtD
Bexarotene—Anorexia—Ramipril—coronary artery disease	3.12e-05	0.000197	CcSEcCtD
Bexarotene—Nausea—Ezetimibe—coronary artery disease	3.11e-05	0.000197	CcSEcCtD
Bexarotene—Skin disorder—Timolol—coronary artery disease	3.1e-05	0.000196	CcSEcCtD
Bexarotene—Dizziness—Olmesartan—coronary artery disease	3.1e-05	0.000196	CcSEcCtD
Bexarotene—Pruritus—Trandolapril—coronary artery disease	3.1e-05	0.000196	CcSEcCtD
Bexarotene—Chest pain—Lisinopril—coronary artery disease	3.09e-05	0.000196	CcSEcCtD
Bexarotene—Myalgia—Lisinopril—coronary artery disease	3.09e-05	0.000196	CcSEcCtD
Bexarotene—Arthralgia—Lisinopril—coronary artery disease	3.09e-05	0.000196	CcSEcCtD
Bexarotene—Hyperhidrosis—Timolol—coronary artery disease	3.09e-05	0.000195	CcSEcCtD
Bexarotene—Asthenia—Telmisartan—coronary artery disease	3.09e-05	0.000195	CcSEcCtD
Bexarotene—Pruritus—Enalapril—coronary artery disease	3.09e-05	0.000195	CcSEcCtD
Bexarotene—Diarrhoea—Pravastatin—coronary artery disease	3.09e-05	0.000195	CcSEcCtD
Bexarotene—Anxiety—Lisinopril—coronary artery disease	3.08e-05	0.000195	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	3.07e-05	0.000194	CcSEcCtD
Bexarotene—Discomfort—Lisinopril—coronary artery disease	3.06e-05	0.000193	CcSEcCtD
Bexarotene—Anorexia—Timolol—coronary artery disease	3.05e-05	0.000193	CcSEcCtD
Bexarotene—Pruritus—Telmisartan—coronary artery disease	3.05e-05	0.000193	CcSEcCtD
Bexarotene—Nausea—Eplerenone—coronary artery disease	3.04e-05	0.000192	CcSEcCtD
Bexarotene—Dizziness—Niacin—coronary artery disease	3.03e-05	0.000192	CcSEcCtD
Bexarotene—Dry mouth—Lisinopril—coronary artery disease	3.03e-05	0.000191	CcSEcCtD
Bexarotene—Body temperature increased—Losartan—coronary artery disease	3.01e-05	0.000191	CcSEcCtD
Bexarotene—Abdominal pain—Losartan—coronary artery disease	3.01e-05	0.000191	CcSEcCtD
Bexarotene—Asthenia—Captopril—coronary artery disease	3e-05	0.00019	CcSEcCtD
Bexarotene—Diarrhoea—Trandolapril—coronary artery disease	3e-05	0.00019	CcSEcCtD
Bexarotene—Vomiting—Valsartan—coronary artery disease	3e-05	0.00019	CcSEcCtD
Bexarotene—Confusional state—Lisinopril—coronary artery disease	2.99e-05	0.000189	CcSEcCtD
Bexarotene—Diarrhoea—Enalapril—coronary artery disease	2.99e-05	0.000189	CcSEcCtD
Bexarotene—Dizziness—Pravastatin—coronary artery disease	2.98e-05	0.000189	CcSEcCtD
Bexarotene—Vomiting—Olmesartan—coronary artery disease	2.98e-05	0.000189	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.98e-05	0.000188	CcSEcCtD
Bexarotene—Rash—Valsartan—coronary artery disease	2.97e-05	0.000188	CcSEcCtD
Bexarotene—Dermatitis—Valsartan—coronary artery disease	2.97e-05	0.000188	CcSEcCtD
Bexarotene—Nausea—Simvastatin—coronary artery disease	2.97e-05	0.000187	CcSEcCtD
Bexarotene—Oedema—Lisinopril—coronary artery disease	2.97e-05	0.000187	CcSEcCtD
Bexarotene—Pruritus—Captopril—coronary artery disease	2.96e-05	0.000187	CcSEcCtD
Bexarotene—Rash—Olmesartan—coronary artery disease	2.96e-05	0.000187	CcSEcCtD
Bexarotene—Insomnia—Ramipril—coronary artery disease	2.96e-05	0.000187	CcSEcCtD
Bexarotene—Dermatitis—Olmesartan—coronary artery disease	2.96e-05	0.000187	CcSEcCtD
Bexarotene—Headache—Valsartan—coronary artery disease	2.95e-05	0.000187	CcSEcCtD
Bexarotene—Diarrhoea—Telmisartan—coronary artery disease	2.95e-05	0.000186	CcSEcCtD
Bexarotene—Infection—Lisinopril—coronary artery disease	2.95e-05	0.000186	CcSEcCtD
Bexarotene—Headache—Olmesartan—coronary artery disease	2.94e-05	0.000186	CcSEcCtD
Bexarotene—Paraesthesia—Ramipril—coronary artery disease	2.94e-05	0.000186	CcSEcCtD
Bexarotene—Shock—Lisinopril—coronary artery disease	2.92e-05	0.000184	CcSEcCtD
Bexarotene—Asthenia—Perindopril—coronary artery disease	2.92e-05	0.000184	CcSEcCtD
Bexarotene—Dyspnoea—Ramipril—coronary artery disease	2.92e-05	0.000184	CcSEcCtD
Bexarotene—Vomiting—Niacin—coronary artery disease	2.91e-05	0.000184	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Timolol—coronary artery disease	2.91e-05	0.000184	CcSEcCtD
Bexarotene—Hypersensitivity—Furosemide—coronary artery disease	2.91e-05	0.000184	CcSEcCtD
Bexarotene—Somnolence—Ramipril—coronary artery disease	2.91e-05	0.000184	CcSEcCtD
Bexarotene—Thrombocytopenia—Lisinopril—coronary artery disease	2.9e-05	0.000184	CcSEcCtD
Bexarotene—Dizziness—Trandolapril—coronary artery disease	2.9e-05	0.000183	CcSEcCtD
Bexarotene—Tachycardia—Lisinopril—coronary artery disease	2.89e-05	0.000183	CcSEcCtD
Bexarotene—Insomnia—Timolol—coronary artery disease	2.89e-05	0.000183	CcSEcCtD
Bexarotene—Rash—Niacin—coronary artery disease	2.89e-05	0.000183	CcSEcCtD
Bexarotene—Dermatitis—Niacin—coronary artery disease	2.89e-05	0.000183	CcSEcCtD
Bexarotene—Dizziness—Enalapril—coronary artery disease	2.89e-05	0.000182	CcSEcCtD
Bexarotene—Skin disorder—Lisinopril—coronary artery disease	2.88e-05	0.000182	CcSEcCtD
Bexarotene—Dyspepsia—Ramipril—coronary artery disease	2.88e-05	0.000182	CcSEcCtD
Bexarotene—Pruritus—Perindopril—coronary artery disease	2.88e-05	0.000182	CcSEcCtD
Bexarotene—Headache—Niacin—coronary artery disease	2.87e-05	0.000182	CcSEcCtD
Bexarotene—Paraesthesia—Timolol—coronary artery disease	2.87e-05	0.000181	CcSEcCtD
Bexarotene—Vomiting—Pravastatin—coronary artery disease	2.87e-05	0.000181	CcSEcCtD
Bexarotene—Hyperhidrosis—Lisinopril—coronary artery disease	2.87e-05	0.000181	CcSEcCtD
Bexarotene—Diarrhoea—Captopril—coronary artery disease	2.86e-05	0.000181	CcSEcCtD
Bexarotene—Dyspnoea—Timolol—coronary artery disease	2.85e-05	0.00018	CcSEcCtD
Bexarotene—Dizziness—Telmisartan—coronary artery disease	2.85e-05	0.00018	CcSEcCtD
Bexarotene—Rash—Pravastatin—coronary artery disease	2.85e-05	0.00018	CcSEcCtD
Bexarotene—Dermatitis—Pravastatin—coronary artery disease	2.84e-05	0.00018	CcSEcCtD
Bexarotene—Decreased appetite—Ramipril—coronary artery disease	2.84e-05	0.00018	CcSEcCtD
Bexarotene—Somnolence—Timolol—coronary artery disease	2.84e-05	0.00018	CcSEcCtD
Bexarotene—Asthenia—Furosemide—coronary artery disease	2.84e-05	0.000179	CcSEcCtD
Bexarotene—Headache—Pravastatin—coronary artery disease	2.83e-05	0.000179	CcSEcCtD
Bexarotene—Anorexia—Lisinopril—coronary artery disease	2.83e-05	0.000179	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Ramipril—coronary artery disease	2.82e-05	0.000178	CcSEcCtD
Bexarotene—Fatigue—Ramipril—coronary artery disease	2.82e-05	0.000178	CcSEcCtD
Bexarotene—Dyspepsia—Timolol—coronary artery disease	2.81e-05	0.000178	CcSEcCtD
Bexarotene—Hypersensitivity—Losartan—coronary artery disease	2.81e-05	0.000178	CcSEcCtD
Bexarotene—Nausea—Valsartan—coronary artery disease	2.8e-05	0.000177	CcSEcCtD
Bexarotene—Pruritus—Furosemide—coronary artery disease	2.8e-05	0.000177	CcSEcCtD
Bexarotene—Constipation—Ramipril—coronary artery disease	2.8e-05	0.000177	CcSEcCtD
Bexarotene—Nausea—Olmesartan—coronary artery disease	2.79e-05	0.000176	CcSEcCtD
Bexarotene—Vomiting—Trandolapril—coronary artery disease	2.79e-05	0.000176	CcSEcCtD
Bexarotene—Diarrhoea—Perindopril—coronary artery disease	2.78e-05	0.000176	CcSEcCtD
Bexarotene—Decreased appetite—Timolol—coronary artery disease	2.78e-05	0.000176	CcSEcCtD
Bexarotene—Vomiting—Enalapril—coronary artery disease	2.78e-05	0.000175	CcSEcCtD
Bexarotene—Dizziness—Captopril—coronary artery disease	2.77e-05	0.000175	CcSEcCtD
Bexarotene—Rash—Trandolapril—coronary artery disease	2.76e-05	0.000175	CcSEcCtD
Bexarotene—Dermatitis—Trandolapril—coronary artery disease	2.76e-05	0.000175	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Timolol—coronary artery disease	2.76e-05	0.000174	CcSEcCtD
Bexarotene—Fatigue—Timolol—coronary artery disease	2.76e-05	0.000174	CcSEcCtD
Bexarotene—Rash—Enalapril—coronary artery disease	2.75e-05	0.000174	CcSEcCtD
Bexarotene—Dermatitis—Enalapril—coronary artery disease	2.75e-05	0.000174	CcSEcCtD
Bexarotene—Headache—Trandolapril—coronary artery disease	2.75e-05	0.000174	CcSEcCtD
Bexarotene—Vomiting—Telmisartan—coronary artery disease	2.74e-05	0.000173	CcSEcCtD
Bexarotene—Asthenia—Losartan—coronary artery disease	2.74e-05	0.000173	CcSEcCtD
Bexarotene—Headache—Enalapril—coronary artery disease	2.73e-05	0.000173	CcSEcCtD
Bexarotene—Pain—Timolol—coronary artery disease	2.73e-05	0.000173	CcSEcCtD
Bexarotene—Nausea—Niacin—coronary artery disease	2.72e-05	0.000172	CcSEcCtD
Bexarotene—Rash—Telmisartan—coronary artery disease	2.72e-05	0.000172	CcSEcCtD
Bexarotene—Dermatitis—Telmisartan—coronary artery disease	2.71e-05	0.000171	CcSEcCtD
Bexarotene—Diarrhoea—Furosemide—coronary artery disease	2.7e-05	0.000171	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.7e-05	0.000171	CcSEcCtD
Bexarotene—Pruritus—Losartan—coronary artery disease	2.7e-05	0.000171	CcSEcCtD
Bexarotene—Headache—Telmisartan—coronary artery disease	2.7e-05	0.000171	CcSEcCtD
Bexarotene—Feeling abnormal—Ramipril—coronary artery disease	2.69e-05	0.00017	CcSEcCtD
Bexarotene—Dizziness—Perindopril—coronary artery disease	2.69e-05	0.00017	CcSEcCtD
Bexarotene—Insomnia—Lisinopril—coronary artery disease	2.68e-05	0.00017	CcSEcCtD
Bexarotene—Nausea—Pravastatin—coronary artery disease	2.68e-05	0.000169	CcSEcCtD
Bexarotene—Gastrointestinal pain—Ramipril—coronary artery disease	2.67e-05	0.000169	CcSEcCtD
Bexarotene—Paraesthesia—Lisinopril—coronary artery disease	2.66e-05	0.000168	CcSEcCtD
Bexarotene—Vomiting—Captopril—coronary artery disease	2.66e-05	0.000168	CcSEcCtD
Bexarotene—Dyspnoea—Lisinopril—coronary artery disease	2.64e-05	0.000167	CcSEcCtD
Bexarotene—Rash—Captopril—coronary artery disease	2.64e-05	0.000167	CcSEcCtD
Bexarotene—Dermatitis—Captopril—coronary artery disease	2.64e-05	0.000167	CcSEcCtD
Bexarotene—Somnolence—Lisinopril—coronary artery disease	2.64e-05	0.000167	CcSEcCtD
Bexarotene—Feeling abnormal—Timolol—coronary artery disease	2.63e-05	0.000167	CcSEcCtD
Bexarotene—Headache—Captopril—coronary artery disease	2.62e-05	0.000166	CcSEcCtD
Bexarotene—Gastrointestinal pain—Timolol—coronary artery disease	2.61e-05	0.000165	CcSEcCtD
Bexarotene—Dizziness—Furosemide—coronary artery disease	2.61e-05	0.000165	CcSEcCtD
Bexarotene—Dyspepsia—Lisinopril—coronary artery disease	2.61e-05	0.000165	CcSEcCtD
Bexarotene—Diarrhoea—Losartan—coronary artery disease	2.61e-05	0.000165	CcSEcCtD
Bexarotene—Nausea—Trandolapril—coronary artery disease	2.6e-05	0.000165	CcSEcCtD
Bexarotene—Nausea—Enalapril—coronary artery disease	2.59e-05	0.000164	CcSEcCtD
Bexarotene—Vomiting—Perindopril—coronary artery disease	2.58e-05	0.000163	CcSEcCtD
Bexarotene—Body temperature increased—Ramipril—coronary artery disease	2.58e-05	0.000163	CcSEcCtD
Bexarotene—Abdominal pain—Ramipril—coronary artery disease	2.58e-05	0.000163	CcSEcCtD
Bexarotene—Decreased appetite—Lisinopril—coronary artery disease	2.58e-05	0.000163	CcSEcCtD
Bexarotene—Rash—Perindopril—coronary artery disease	2.56e-05	0.000162	CcSEcCtD
Bexarotene—Dermatitis—Perindopril—coronary artery disease	2.56e-05	0.000162	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.56e-05	0.000162	CcSEcCtD
Bexarotene—Nausea—Telmisartan—coronary artery disease	2.56e-05	0.000162	CcSEcCtD
Bexarotene—Fatigue—Lisinopril—coronary artery disease	2.56e-05	0.000162	CcSEcCtD
Bexarotene—Headache—Perindopril—coronary artery disease	2.55e-05	0.000161	CcSEcCtD
Bexarotene—Pain—Lisinopril—coronary artery disease	2.54e-05	0.00016	CcSEcCtD
Bexarotene—Constipation—Lisinopril—coronary artery disease	2.54e-05	0.00016	CcSEcCtD
Bexarotene—Body temperature increased—Timolol—coronary artery disease	2.53e-05	0.00016	CcSEcCtD
Bexarotene—Abdominal pain—Timolol—coronary artery disease	2.53e-05	0.00016	CcSEcCtD
Bexarotene—Dizziness—Losartan—coronary artery disease	2.52e-05	0.000159	CcSEcCtD
Bexarotene—Vomiting—Furosemide—coronary artery disease	2.51e-05	0.000159	CcSEcCtD
Bexarotene—Rash—Furosemide—coronary artery disease	2.49e-05	0.000158	CcSEcCtD
Bexarotene—Dermatitis—Furosemide—coronary artery disease	2.49e-05	0.000157	CcSEcCtD
Bexarotene—Nausea—Captopril—coronary artery disease	2.49e-05	0.000157	CcSEcCtD
Bexarotene—Headache—Furosemide—coronary artery disease	2.48e-05	0.000157	CcSEcCtD
Bexarotene—Feeling abnormal—Lisinopril—coronary artery disease	2.44e-05	0.000154	CcSEcCtD
Bexarotene—Gastrointestinal pain—Lisinopril—coronary artery disease	2.42e-05	0.000153	CcSEcCtD
Bexarotene—Vomiting—Losartan—coronary artery disease	2.42e-05	0.000153	CcSEcCtD
Bexarotene—Nausea—Perindopril—coronary artery disease	2.41e-05	0.000153	CcSEcCtD
Bexarotene—Hypersensitivity—Ramipril—coronary artery disease	2.41e-05	0.000152	CcSEcCtD
Bexarotene—Rash—Losartan—coronary artery disease	2.4e-05	0.000152	CcSEcCtD
Bexarotene—Dermatitis—Losartan—coronary artery disease	2.4e-05	0.000152	CcSEcCtD
Bexarotene—Headache—Losartan—coronary artery disease	2.39e-05	0.000151	CcSEcCtD
Bexarotene—Hypersensitivity—Timolol—coronary artery disease	2.36e-05	0.000149	CcSEcCtD
Bexarotene—Nausea—Furosemide—coronary artery disease	2.35e-05	0.000148	CcSEcCtD
Bexarotene—Asthenia—Ramipril—coronary artery disease	2.35e-05	0.000148	CcSEcCtD
Bexarotene—Body temperature increased—Lisinopril—coronary artery disease	2.34e-05	0.000148	CcSEcCtD
Bexarotene—Abdominal pain—Lisinopril—coronary artery disease	2.34e-05	0.000148	CcSEcCtD
Bexarotene—Pruritus—Ramipril—coronary artery disease	2.31e-05	0.000146	CcSEcCtD
Bexarotene—Asthenia—Timolol—coronary artery disease	2.29e-05	0.000145	CcSEcCtD
Bexarotene—Nausea—Losartan—coronary artery disease	2.27e-05	0.000143	CcSEcCtD
Bexarotene—Pruritus—Timolol—coronary artery disease	2.26e-05	0.000143	CcSEcCtD
Bexarotene—Diarrhoea—Ramipril—coronary artery disease	2.24e-05	0.000141	CcSEcCtD
Bexarotene—Diarrhoea—Timolol—coronary artery disease	2.19e-05	0.000138	CcSEcCtD
Bexarotene—Hypersensitivity—Lisinopril—coronary artery disease	2.18e-05	0.000138	CcSEcCtD
Bexarotene—Dizziness—Ramipril—coronary artery disease	2.16e-05	0.000137	CcSEcCtD
Bexarotene—Asthenia—Lisinopril—coronary artery disease	2.13e-05	0.000134	CcSEcCtD
Bexarotene—Dizziness—Timolol—coronary artery disease	2.11e-05	0.000134	CcSEcCtD
Bexarotene—Pruritus—Lisinopril—coronary artery disease	2.1e-05	0.000133	CcSEcCtD
Bexarotene—Vomiting—Ramipril—coronary artery disease	2.08e-05	0.000131	CcSEcCtD
Bexarotene—Rash—Ramipril—coronary artery disease	2.06e-05	0.00013	CcSEcCtD
Bexarotene—Dermatitis—Ramipril—coronary artery disease	2.06e-05	0.00013	CcSEcCtD
Bexarotene—Headache—Ramipril—coronary artery disease	2.05e-05	0.000129	CcSEcCtD
Bexarotene—Vomiting—Timolol—coronary artery disease	2.03e-05	0.000128	CcSEcCtD
Bexarotene—Diarrhoea—Lisinopril—coronary artery disease	2.03e-05	0.000128	CcSEcCtD
Bexarotene—Rash—Timolol—coronary artery disease	2.02e-05	0.000127	CcSEcCtD
Bexarotene—Dermatitis—Timolol—coronary artery disease	2.01e-05	0.000127	CcSEcCtD
Bexarotene—Headache—Timolol—coronary artery disease	2e-05	0.000127	CcSEcCtD
Bexarotene—Dizziness—Lisinopril—coronary artery disease	1.96e-05	0.000124	CcSEcCtD
Bexarotene—Nausea—Ramipril—coronary artery disease	1.94e-05	0.000123	CcSEcCtD
Bexarotene—Nausea—Timolol—coronary artery disease	1.9e-05	0.00012	CcSEcCtD
Bexarotene—Vomiting—Lisinopril—coronary artery disease	1.89e-05	0.000119	CcSEcCtD
Bexarotene—Rash—Lisinopril—coronary artery disease	1.87e-05	0.000118	CcSEcCtD
Bexarotene—Dermatitis—Lisinopril—coronary artery disease	1.87e-05	0.000118	CcSEcCtD
Bexarotene—Headache—Lisinopril—coronary artery disease	1.86e-05	0.000117	CcSEcCtD
Bexarotene—Nausea—Lisinopril—coronary artery disease	1.76e-05	0.000111	CcSEcCtD
Bexarotene—CYP2C9—Metabolism—GCH1—coronary artery disease	8.43e-06	9.9e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	8.33e-06	9.79e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PLCB1—coronary artery disease	8.27e-06	9.71e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	8.24e-06	9.68e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	8.11e-06	9.52e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPAT—coronary artery disease	8.08e-06	9.49e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—UGCG—coronary artery disease	8.08e-06	9.49e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLCD1—coronary artery disease	8.08e-06	9.49e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—MDH2—coronary artery disease	8.08e-06	9.49e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ABCA1—coronary artery disease	8.01e-06	9.41e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP9—coronary artery disease	7.96e-06	9.35e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PGM1—coronary artery disease	7.78e-06	9.14e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GGT1—coronary artery disease	7.76e-06	9.11e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GOT1—coronary artery disease	7.76e-06	9.11e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	7.6e-06	8.93e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPP2CA—coronary artery disease	7.59e-06	8.91e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	7.54e-06	8.85e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PYGB—coronary artery disease	7.51e-06	8.82e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CKB—coronary artery disease	7.51e-06	8.82e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PRKCD—coronary artery disease	7.45e-06	8.75e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—VEGFA—coronary artery disease	7.15e-06	8.4e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PFKFB3—coronary artery disease	7.06e-06	8.3e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—DLAT—coronary artery disease	7.06e-06	8.3e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTM2—coronary artery disease	7.06e-06	8.3e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLIN1—coronary artery disease	7.06e-06	8.3e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—COX5B—coronary artery disease	7.06e-06	8.3e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	7.03e-06	8.26e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CKM—coronary artery disease	7.03e-06	8.26e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPAP2B—coronary artery disease	7.03e-06	8.26e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTP1—coronary artery disease	6.97e-06	8.19e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARGC1A—coronary artery disease	6.91e-06	8.11e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—HMOX1—coronary artery disease	6.87e-06	8.07e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CAT—coronary artery disease	6.78e-06	7.97e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	6.72e-06	7.89e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SULT1E1—coronary artery disease	6.7e-06	7.86e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—MAPK14—coronary artery disease	6.6e-06	7.75e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOB—coronary artery disease	6.58e-06	7.73e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TGFB1—coronary artery disease	6.56e-06	7.71e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PYGM—coronary artery disease	6.54e-06	7.68e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SULT4A1—coronary artery disease	6.54e-06	7.68e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PDK4—coronary artery disease	6.54e-06	7.68e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	6.54e-06	7.68e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CKMT2—coronary artery disease	6.54e-06	7.68e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—POMC—coronary artery disease	6.52e-06	7.65e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	6.5e-06	7.64e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—ESR1—coronary artery disease	6.47e-06	7.6e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MAPK1—coronary artery disease	6.44e-06	7.56e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTM1—coronary artery disease	6.41e-06	7.52e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HK2—coronary artery disease	6.39e-06	7.5e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AKR1B1—coronary artery disease	6.39e-06	7.5e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—LPL—coronary artery disease	6.29e-06	7.38e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GPX1—coronary artery disease	6.13e-06	7.2e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TNF—coronary artery disease	6.13e-06	7.2e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC27A1—coronary artery disease	6.13e-06	7.19e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LCAT—coronary artery disease	6.01e-06	7.05e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CPT1B—coronary artery disease	6.01e-06	7.05e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CD36—coronary artery disease	5.97e-06	7.02e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPARG—coronary artery disease	5.9e-06	6.93e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPP2CA—coronary artery disease	5.9e-06	6.93e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOA4—coronary artery disease	5.9e-06	6.92e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PFKM—coronary artery disease	5.83e-06	6.84e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LDHA—coronary artery disease	5.83e-06	6.84e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GK—coronary artery disease	5.83e-06	6.84e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HMGCS2—coronary artery disease	5.83e-06	6.84e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GYG1—coronary artery disease	5.83e-06	6.84e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GATM—coronary artery disease	5.83e-06	6.84e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	5.79e-06	6.8e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PDHA1—coronary artery disease	5.69e-06	6.69e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GCLM—coronary artery disease	5.69e-06	6.69e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—MTHFR—coronary artery disease	5.66e-06	6.65e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GCH1—coronary artery disease	5.56e-06	6.53e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AK1—coronary artery disease	5.56e-06	6.53e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	5.52e-06	6.48e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TXNRD1—coronary artery disease	5.51e-06	6.48e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP11B2—coronary artery disease	5.51e-06	6.48e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC22A3—coronary artery disease	5.43e-06	6.38e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AGT—coronary artery disease	5.38e-06	6.32e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HADH—coronary artery disease	5.35e-06	6.29e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ARNTL—coronary artery disease	5.35e-06	6.29e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MDH2—coronary artery disease	5.33e-06	6.26e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—UGCG—coronary artery disease	5.33e-06	6.26e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPAT—coronary artery disease	5.33e-06	6.26e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLCD1—coronary artery disease	5.33e-06	6.26e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—SERPINE1—coronary artery disease	5.32e-06	6.25e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	5.27e-06	6.19e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOE—coronary artery disease	5.27e-06	6.19e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOA1—coronary artery disease	5.21e-06	6.12e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	5.14e-06	6.04e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PGM1—coronary artery disease	5.13e-06	6.03e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GPX2—coronary artery disease	5.08e-06	5.96e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLA2G2A—coronary artery disease	5.08e-06	5.96e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOA2—coronary artery disease	5.08e-06	5.96e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ABCG5—coronary artery disease	5.01e-06	5.89e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GPX4—coronary artery disease	5.01e-06	5.89e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HK1—coronary artery disease	5.01e-06	5.89e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SULT1A1—coronary artery disease	5.01e-06	5.89e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	5.01e-06	5.88e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.99e-06	5.86e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PYGB—coronary artery disease	4.96e-06	5.82e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CKB—coronary artery disease	4.96e-06	5.82e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HADHA—coronary artery disease	4.95e-06	5.82e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IL6—coronary artery disease	4.95e-06	5.81e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTA1—coronary artery disease	4.9e-06	5.75e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LPA—coronary artery disease	4.84e-06	5.69e-05	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—AKT1—coronary artery disease	4.76e-06	5.59e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLCB3—coronary artery disease	4.69e-06	5.51e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLIN1—coronary artery disease	4.66e-06	5.47e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—COX5B—coronary artery disease	4.66e-06	5.47e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTM2—coronary artery disease	4.66e-06	5.47e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—DLAT—coronary artery disease	4.66e-06	5.47e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PFKFB3—coronary artery disease	4.66e-06	5.47e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOA5—coronary artery disease	4.64e-06	5.45e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARG—coronary artery disease	4.59e-06	5.39e-05	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—AKT1—coronary artery disease	4.56e-06	5.36e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—P4HB—coronary artery disease	4.55e-06	5.35e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—POMC—coronary artery disease	4.53e-06	5.32e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	4.51e-06	5.3e-05	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—AKT1—coronary artery disease	4.48e-06	5.26e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	4.47e-06	5.25e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	4.42e-06	5.19e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SULT1E1—coronary artery disease	4.42e-06	5.19e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	4.37e-06	5.13e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AKR1B1—coronary artery disease	4.21e-06	4.95e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HK2—coronary artery disease	4.21e-06	4.95e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—VCAN—coronary artery disease	4.21e-06	4.95e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALDOA—coronary artery disease	4.18e-06	4.91e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALB—coronary artery disease	4.13e-06	4.85e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—DCN—coronary artery disease	4.06e-06	4.77e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC27A1—coronary artery disease	4.04e-06	4.74e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LCAT—coronary artery disease	3.96e-06	4.65e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CPT1B—coronary artery disease	3.96e-06	4.65e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NOS3—coronary artery disease	3.95e-06	4.64e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALDH2—coronary artery disease	3.95e-06	4.64e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOA4—coronary artery disease	3.89e-06	4.57e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	3.85e-06	4.52e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LIPC—coronary artery disease	3.85e-06	4.52e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HBA1—coronary artery disease	3.85e-06	4.52e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	3.85e-06	4.52e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP2C19—coronary artery disease	3.85e-06	4.52e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOC3—coronary artery disease	3.82e-06	4.49e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LDLR—coronary artery disease	3.8e-06	4.46e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	3.8e-06	4.46e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PDHA1—coronary artery disease	3.76e-06	4.41e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GCLM—coronary artery disease	3.76e-06	4.41e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTT1—coronary artery disease	3.75e-06	4.41e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC9A1—coronary artery disease	3.75e-06	4.41e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GCLC—coronary artery disease	3.71e-06	4.36e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CETP—coronary artery disease	3.71e-06	4.36e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SDC1—coronary artery disease	3.67e-06	4.31e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP11B2—coronary artery disease	3.64e-06	4.27e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TXNRD1—coronary artery disease	3.64e-06	4.27e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGS2—coronary artery disease	3.61e-06	4.24e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC22A3—coronary artery disease	3.58e-06	4.21e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ARNTL—coronary artery disease	3.53e-06	4.15e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HADH—coronary artery disease	3.53e-06	4.15e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PSMA6—coronary artery disease	3.47e-06	4.07e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PSMB5—coronary artery disease	3.47e-06	4.07e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.46e-06	4.06e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CTGF—coronary artery disease	3.39e-06	3.98e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HMGCR—coronary artery disease	3.36e-06	3.94e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GOT2—coronary artery disease	3.36e-06	3.94e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	3.35e-06	3.93e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOA2—coronary artery disease	3.35e-06	3.93e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GPX2—coronary artery disease	3.35e-06	3.93e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GPX4—coronary artery disease	3.31e-06	3.88e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ABCG5—coronary artery disease	3.31e-06	3.88e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SULT1A1—coronary artery disease	3.31e-06	3.88e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HK1—coronary artery disease	3.31e-06	3.88e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HADHA—coronary artery disease	3.27e-06	3.84e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.23e-06	3.79e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LPA—coronary artery disease	3.19e-06	3.75e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.09e-06	3.63e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLCB1—coronary artery disease	3.09e-06	3.62e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOA5—coronary artery disease	3.06e-06	3.6e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.03e-06	3.56e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—P4HB—coronary artery disease	3e-06	3.53e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ABCA1—coronary artery disease	2.99e-06	3.51e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.95e-06	3.46e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GOT1—coronary artery disease	2.9e-06	3.4e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GGT1—coronary artery disease	2.9e-06	3.4e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—VCAN—coronary artery disease	2.78e-06	3.26e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.76e-06	3.24e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—DCN—coronary artery disease	2.68e-06	3.14e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.6e-06	3.06e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTP1—coronary artery disease	2.6e-06	3.06e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	2.58e-06	3.03e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HMOX1—coronary artery disease	2.57e-06	3.01e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HBA1—coronary artery disease	2.54e-06	2.98e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LIPC—coronary artery disease	2.54e-06	2.98e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.54e-06	2.98e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.54e-06	2.98e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CAT—coronary artery disease	2.53e-06	2.97e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOC3—coronary artery disease	2.52e-06	2.96e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LDLR—coronary artery disease	2.51e-06	2.94e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.48e-06	2.91e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.48e-06	2.91e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOB—coronary artery disease	2.46e-06	2.89e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GCLC—coronary artery disease	2.45e-06	2.87e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CETP—coronary artery disease	2.45e-06	2.87e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SDC1—coronary artery disease	2.42e-06	2.84e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTM1—coronary artery disease	2.39e-06	2.81e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LPL—coronary artery disease	2.35e-06	2.76e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—AKT1—coronary artery disease	2.33e-06	2.74e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GPX1—coronary artery disease	2.29e-06	2.69e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.29e-06	2.68e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.29e-06	2.68e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CTGF—coronary artery disease	2.23e-06	2.62e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CD36—coronary artery disease	2.23e-06	2.62e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CA—coronary artery disease	2.22e-06	2.61e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.21e-06	2.6e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GOT2—coronary artery disease	2.21e-06	2.6e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPP2CA—coronary artery disease	2.2e-06	2.59e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—MTHFR—coronary artery disease	2.11e-06	2.48e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.04e-06	2.39e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AGT—coronary artery disease	2.01e-06	2.36e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.97e-06	2.32e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOE—coronary artery disease	1.97e-06	2.31e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOA1—coronary artery disease	1.94e-06	2.28e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GGT1—coronary artery disease	1.91e-06	2.24e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GOT1—coronary artery disease	1.91e-06	2.24e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.86e-06	2.19e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AKT1—coronary artery disease	1.81e-06	2.13e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.72e-06	2.02e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARG—coronary artery disease	1.71e-06	2.01e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.7e-06	2e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.69e-06	1.99e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—POMC—coronary artery disease	1.69e-06	1.98e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CAT—coronary artery disease	1.67e-06	1.96e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOB—coronary artery disease	1.62e-06	1.9e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.58e-06	1.85e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LPL—coronary artery disease	1.55e-06	1.82e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALB—coronary artery disease	1.54e-06	1.81e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GPX1—coronary artery disease	1.51e-06	1.77e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NOS3—coronary artery disease	1.47e-06	1.73e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CD36—coronary artery disease	1.47e-06	1.73e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.45e-06	1.71e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.39e-06	1.64e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.35e-06	1.58e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AGT—coronary artery disease	1.32e-06	1.56e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOE—coronary artery disease	1.3e-06	1.52e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOA1—coronary artery disease	1.28e-06	1.51e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARG—coronary artery disease	1.13e-06	1.33e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—POMC—coronary artery disease	1.11e-06	1.31e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALB—coronary artery disease	1.02e-06	1.19e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NOS3—coronary artery disease	9.72e-07	1.14e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS2—coronary artery disease	8.89e-07	1.04e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CA—coronary artery disease	8.29e-07	9.74e-06	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AKT1—coronary artery disease	6.78e-07	7.96e-06	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CA—coronary artery disease	5.47e-07	6.42e-06	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AKT1—coronary artery disease	4.47e-07	5.25e-06	CbGpPWpGaD
